"Accelerated ear-age": A new measure of chemotherapy-induced ototoxicity

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 947-949

  Fligor, Brian J ^a,b   Krasker, Jennie D ^c   Villaluna, Doojduen ^d   Krailo, Mark ^d   Frazier, A Lindsay ^b,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WELLESLEY COLLEGE   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Ototoxicity; Pediatric hematology oncology; Pediatric oncology

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; ARTICLE; AUDIOGRAPHY; AUDITORY SYSTEM PARAMETERS; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EAR AGE; HEARING; HEARING LOSS; HUMAN; OTOTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HEARING LOSS, HIGH-FREQUENCY; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL;

EID: 84866143503     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24169     Document Type: Article

References (16)

1. Travis LB, Beard C, Allan JM, et al. Testicular cancer survivorship: Research strategies and recommendations. J Natl Cancer Inst 2010; 102: 1114-1130.
2. Bertolini P, Lassalle M, Mercier G, et al. Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol 2004; 26: 649-655.
3. Henderson D, Bielefeld EC, Harris KC, et al. The role of oxidative stress in noise-induced hearing loss. Ear Hear 2006; 27: 1-19.
4. Stelmachowicz PG, Pittman AL, Hoover BM, et al. The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch Otolaryngol Head Neck Surg 2004; 130: 556-562.
5. Li Y, Womer RB, Silber JH. Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer 2004; 40: 2445-2451.
6. Li Y, Womer RB, Silber JH. A decision analysis balancing survival and cisplatin ototoxicity in children with germ cell tumors. Oral Abstract Session, Pediatric Cancer I Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005; 8502.
7. Brock PR, Bellman SC, Yeomans EC, et al. Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol 1991; 19: 295-300.
8. National Cancer Institute. Common terminology criteria for adverse events, Version 3.0. Publish Date August 9, 2006; Available at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.
9. Lewis MJ, DuBois SG, Fligor B, et al. Ototoxicity in children treated for osteosarcoma. Pediatr Blood Cancer 2009; 52: 387-391.
10. Chang KW, Chinosornvatana N. Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 2010; 28: 1788-1795.
11. Brock P, Knight K, Freyer DR, et al. Platinum-induced ototoxicity in children: A consensus review on mechanisms, predisposition and protection including a new SIOP Boston Ototoxicity Scale. J Clin Oncol (in press).
12. Shargorodsky J, Curhan SG, Curhan GC, et al. Change in prevalence of hearing loss in US adolescents. J Am Med Assoc 2010; 304: 772-778.
13. Johnson D. One rock concert=21/2 year aging. Spectrum 1988; 5, Reprinted Spectrum 2003; 20: 6-7.
14. Kenna MA, Feldman HA, Neault MW, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg 2010; 136: 81-87.
15. American National Standards Institute. "Hearing threshold level associated with age (HTLA) for an otologically normal population ("highly screened")." In determination of occupational noise exposure and estimation of noise-induced hearing impairment. S3.44. New York, New York: Acoustical Society of America; 1996, 12-13.
16. Musial-Bright L, Fengler R, Henze G, et al. Carboplatin and ototoxicity: Hearing loss rates among survivors of childhood medulloblastoma. Childs Nerv Syst 2011; 27: 407-413.